Chair for Molecular Nutritional Medicine, TUM School of Life Sciences, Technical University of Munich, Gregor-Mendel-Str. 2, 85354 Freising, Germany.
Int J Mol Sci. 2022 Feb 22;23(5):2406. doi: 10.3390/ijms23052406.
Mitochondrial uncoupling protein 1 (UCP1) is the crucial mechanistic component of heat production in classical brown fat and the newly identified beige or brite fat. Thermogenesis inevitably comes at a high energetic cost and brown fat, ultimately, is an energy-wasting organ. A constrained strategy that minimizes brown fat activity unless obligate will have been favored during natural selection to safeguard metabolic thriftiness. Accordingly, UCP1 is constitutively inhibited and is inherently not leaky without activation. It follows that increasing brown adipocyte number or UCP1 abundance genetically or pharmacologically does not lead to an automatic increase in thermogenesis or subsequent metabolic consequences in the absence of a plausible route of concomitant activation. Despite its apparent obviousness, this tenet is frequently ignored. Consequently, incorrect conclusions are often drawn from increased BAT or brite/beige depot mass, e.g., predicting or causally linking beneficial metabolic effects. Here, we highlight the inherently inactive nature of UCP1, with a particular emphasis on the molecular brakes and releases of UCP1 activation under physiological conditions. These controls of UCP1 activity represent potential targets of therapeutic interventions to unlock constraints and efficiently harness the energy-expending potential of brown fat to prevent and treat obesity and associated metabolic disorders.
解偶联蛋白 1(UCP1)是经典棕色脂肪产热的关键机制组成部分,也是新发现的米色或白色脂肪的关键机制组成部分。产热不可避免地需要付出高昂的能量代价,而棕色脂肪最终是一种浪费能量的器官。在自然选择过程中,一种限制策略会被优先选择,这种策略最大限度地减少棕色脂肪的活动,除非是必需的,以保障代谢节俭。因此,UCP1 被持续抑制,在没有激活的情况下,它本身不会发生渗漏。这意味着,在没有合理的伴随激活途径的情况下,通过遗传或药理学增加棕色脂肪细胞数量或 UCP1 丰度,并不会自动导致产热增加或随后的代谢后果。尽管这一原则显而易见,但它经常被忽视。因此,人们经常从增加 BAT 或 brite/beige 脂肪组织的量中得出错误的结论,例如,预测或因果关联有益的代谢效应。在这里,我们强调了 UCP1 的固有非活性性质,特别强调了生理条件下 UCP1 激活的分子制动器和释放器。这些对 UCP1 活性的控制可能成为治疗干预的潜在靶点,以释放限制,有效地利用棕色脂肪的能量消耗潜力,预防和治疗肥胖症及相关代谢紊乱。